Property, Plant and Equipment [Abstract] Schedule Of Property And Equipment Property, Plant and Equipment [Table Text Block] Fair Value Disclosures [Abstract] Schedule Of Available-For-Sale Securities Available-for-sale Securities [Table Text Block] Schedule Of Available-For-Sale Investments Measured At Fair Value On Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Income Tax Disclosure [Abstract] Income Taxes Income Tax Disclosure [Text Block] Valuation and Qualifying Accounts [Abstract] Valuation and Qualifying Accounts Disclosure [Table] Valuation and Qualifying Accounts Disclosure [Table] Valuation Allowances and Reserves Type [Axis] Valuation Allowances and Reserves Type [Axis] Valuation Allowances and Reserves [Domain] Valuation Allowances and Reserves [Domain] Allowance for Doubtful Accounts [Member] Allowance for Doubtful Accounts [Member] Allowance for Sales Discounts [Member] Allowance For Sales Discounts [Member] Allowance For Sales Discounts [Member] Allowance for Chargebacks [Member] Allowance For Chargebacks [Member] Allowance For Chargebacks [Member] Deferred Tax Asset Valuation Allowance [Member] Valuation Allowance of Deferred Tax Assets [Member] Valuation and Qualifying Accounts Disclosure [Line Items] Valuation and Qualifying Accounts Disclosure [Line Items] Movement in Valuation Allowances and Reserves [Roll Forward] Movement in Valuation Allowances and Reserves [Roll Forward] Balance at beginning of period Valuation Allowances and Reserves, Balance Additions charged to costs and expenses Valuation Allowances and Reserves, Charged to Cost and Expense Other Additions Valuation Allowances and Reserves, Adjustments Deductions Valuation Allowances and Reserves, Deductions Balance at end of period Other Liabilities [Abstract] Other Long Term Liabilities [Table] Other Long Term Liabilities [Table] Other Long Term Liabilities [Table] Deferred Revenue Arrangement Type [Axis] Deferred Revenue Arrangement Type [Axis] Deferred Revenue Arrangement Type [Domain] Deferred Revenue [Domain] UCB Pharma Limited [Member] Ucb Pharma Limited [Member] UCB Pharma Limited [Member] Other Long Term Liabilities [Line Items] Other Long Term Liabilities [Line Items] Other Long Term Liabilities [Line Items] Contract revenues Contracts Revenue Payments received upfront from UCB Deferred Revenue, Payments Received Upfront Deferred Revenue, Payments Received Upfront Deferred contract revenues upfront payment received Gross Deferred Upfront Payments Received Upfront payments previously received related to deferred contract revenue. Quarterly Financial Information Disclosure [Abstract] Quarterly Financial Data [Table] Quarterly Financial Data [Table] Quarterly Financial Data [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Acquired Developed Technologies [Member] Developed Technology Rights [Member] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Azur Pharma [Member] Azur Pharma [Member] Azur Pharma [Member] Contingent Consideration by Type [Axis] Contingent Consideration by Type [Axis] Contingent Consideration Type [Domain] Contingent Consideration Type [Domain] Milestone Payment [Member] Milestone Payment [Member] Milestone Payment [Member] Quarterly Financial Data [Line Items] Quarterly Financial Data [Line Items] Quarterly Financial Data [Line Items] Revenues Revenues Gross margin Gross Profit Net income attributable to Jazz Pharmaceuticals plc Net Income (Loss) Attributable to Parent Net income attributable to Jazz Pharmaceuticals plc per ordinary share, basic (in dollars per share) Earnings Per Share, Basic Net income attributable to Jazz Pharmaceuticals plc per ordinary share, diluted (in dollars per share) Earnings Per Share, Diluted Impairment charges Asset Impairment Charges Research and development Research and Development Expense Acquired in-process research and development Research and Development Asset Acquired Other than Through Business Combination, Written-off Contract claim settlement Loss Contingency, Loss in Period Loss on extinguishment and modification of debt Gain (Loss) on Extinguishment and Modification of Debt Amount includes write-off of deferred debt financing costs, unamortized original issue debt discount and lender fees related to the early extinguishment and modification of debt. Fair value step-up adjustments, purchase accounting inventory Assets, Fair Value Adjustment Transaction costs Business Combination, Acquisition Related Costs Income Statement [Abstract] Revenues: Revenues [Abstract] Product sales, net Sales Revenue, Goods, Net Royalties and contract revenues Royalties And Contract Revenues Royalties revenue earned during the period from the leasing or otherwise lending to a third party the entity's rights or title to certain property and contract revenue earned during the period arising from products sold or services provided under the terms of a contract related to a particular project or product. Total revenues Operating expenses: Operating Expenses [Abstract] Cost of product sales (excluding amortization and impairment of intangible assets) Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment Total costs related to goods produced and sold during the reporting period excluding amortization of acquired developed technologies and intangible asset impairment presented separately. Selling, general and administrative Selling, General and Administrative Expense Intangible asset amortization Amortization of Intangible Assets Total operating expenses Operating Expenses Income from operations Operating Income (Loss) Interest expense, net Interest Income (Expense), Nonoperating, Net Foreign currency gain (loss) Other Nonoperating Income (Expense) Loss on extinguishment and modification of debt Income before income tax provision Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest Income tax provision Income Tax Expense (Benefit) Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss attributable to noncontrolling interests, net of tax Net Income (Loss) Attributable to Noncontrolling Interest Net income attributable to Jazz Pharmaceuticals plc Basic, net income (in dollars per share) Diluted, net income (in dollars per share) Weighted-average ordinary shares used in calculating net income (loss) attributable to Jazz Pharmaceuticals plc per ordinary share: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic (in shares) Weighted Average Number of Shares Outstanding, Basic Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Commitments and Contingencies Disclosure [Abstract] Other Commitments [Table] Other Commitments [Table] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Office Building [Member] Building [Member] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] Palo Alto [Member] Palo Alto [Member] Palo Alto [Member] Contract [Axis] Contract [Axis] Contract [Axis] Contract [Domain] Contract [Domain] [Domain] for Contract [Axis] Lease Agreements [Member] Lease Agreements [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Property, Plant and Equipment [Member] Property, Plant and Equipment [Member] Other Commitments [Line Items] Other Commitments [Line Items] Lease expense Operating Leases, Rent Expense Operating lease, term (in years) Lessee Leasing Arrangements, Operating Leases, Term of Contract Number of renewal option terms Lessee Leasing Arrangement, Operating Leases, Number Of Renewal Terms Number of renewal terms of the lessee's leasing arrangement. Operating lease, extended term option (in years) Operating Lease Extended Term Extended term option period for operating lease. Total future lease payments Operating Leases, Future Minimum Payments Due Construction-in-progress Construction in Progress, Gross Noncancelable purchase commitments due within one year Unrecorded Unconditional Purchase Obligation, Due in Next Twelve Months Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Income Tax Authority [Axis] Income Tax Authority [Axis] Income Tax Authority [Domain] Income Tax Authority [Domain] Non-Taxable Jurisdiction [Member] Non-Taxable Jurisdiction [Member] Non-Taxable Jurisdiction [Member] Ireland [Member] Domestic Tax Authority [Member] U.S. Federal [Member] Internal Revenue Service (IRS) [Member] U.S. State [Member] State and Local Jurisdiction [Member] Foreign Tax Authorities [Member] Foreign Tax Authority [Member] French Tax Authorities [Member] FRANCE Aerial and Defibrotide in Americas [Member] Aerial And Defibrotide VOD Tx (US) [Member] Aerial And Defibrotide VOD Tx (US) [Member] EUSA Pharma Acquisition [Member] Eusa Pharma [Member] Eusa Pharma [Member] United Kingdom [Member] UNITED KINGDOM Italy [Member] ITALY Type of Deferred Compensation [Axis] Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Axis] Type of Deferred Compensation, All Types [Domain] Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Domain] Employee Share Options [Member] Employee Stock Option [Member] Operating Loss Carryforwards by Expiration Period [Axis] Operating Loss Carryforwards by Expiration Period [Axis] Operating Loss Carryforwards by Expiration Period [Axis] Operating Loss Carryforwards, Expiration Period [Domain] Operating Loss Carryforwards, Expiration Period [Domain] Operating Loss Carryforwards, Expiration Period [Domain] Year 2016 [Member] Expiration Next Twelve Months [Member] Expiration Next Twelve Months [Member] Year 2017 to 2026 [Member] Expiration Year Five Through Year Twelve [Member] Expiration Year Five Through Year Twelve [Member] Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Tax rate excluding certain milestone payments Modified Effective Income Tax Rate, Continuing Operations Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations modified to exclude specific items. Statutory income tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Net change in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Non-recurring income tax benefit Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount NOL carryforwards Operating Loss Carryforwards Tax credit carryforwards Tax Credit Carryforward, Amount Annual limitation on utilization of certain acquired federal NOLs Operating Loss Carryforwards, Annual Limitation on Use Operating Loss Carryforwards, Annual Limitation on Use Deferred tax assets, valuation allowance Deferred Tax Assets, Valuation Allowance Cumulated unremitted earnings of overseas subsidiaries Undistributed Earnings of Foreign Subsidiaries Unrecognized tax benefits that would impact the effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Income Tax Examination, Estimate of Possible Loss Income Tax Examination, Estimate of Possible Loss Schedule II Valuation and Qualifying Accounts Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Debt Disclosure [Abstract] Schedule of long-term debt Schedule of Long-term Debt Instruments [Table Text Block] Schedule of maturities of long-term debt Schedule of Maturities of Long-term Debt [Table Text Block] Quarterly Financial Data (Unaudited) Quarterly Financial Information [Text Block] Inventory Disclosure [Abstract] Components of Inventories Inventory, Net, Items Net of Reserve Alternative [Abstract] Raw materials Inventory, Raw Materials, Net of Reserves Work in process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Total inventories Inventory, Net Accounting Policies [Abstract] Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Products and Services [Axis] Products and Services [Axis] Products and Services [Domain] Products and Services [Domain] Xyrem [Member] Xyrem [Member] Xyrem [Member] Erwinaze And Erwinase [Member] Erwinaze And Erwinase [Member] Erwinaze And Erwinase [Member] Defitelio/defibrotide [Member] Defitelio/Defibrotide [Member] Defitelio/Defibrotide [Member] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Product Concentration Risk [Member] Product Concentration Risk [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Sales Revenue, Product Line [Member] Sales Revenue, Product Line [Member] Customer [Axis] Customer [Axis] Customer [Domain] Customer [Domain] Express Scripts [Member] Express Scripts [Member] Express Scripts 1 [Member] Idis Limited [Member] Idis Limited [Member] Idis Limited [Member] Accredo Health Group, Inc. [Member] Accredo Health Group, Inc. [Member] Accredo Health Group, Inc. [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum [Member] Minimum [Member] Maximum [Member] Maximum [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Convertible Debt [Member] Convertible Debt [Member] Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Percentage of total revenues Concentration Risk, Percentage Number of ANDAs filed by third parties Loss Contingency, Pending Claims, Number Number of additional ANDA applicants Number Of Additional New Drug Application Applicants Number Of Additional New Drug Application Applicants Number of customer with significant accounts receivable Number Of Customers With Significant Accounts Receivable Balance Number of customers with significant amount of gross accounts receivable. Percentage of gross accounts receivable Entity Wide Accounts Receivable Major Customer Percentage Percentage of accounts receivable with significant customer Estimated useful life of property and equipment Property, Plant and Equipment, Useful Life Intangible assets, useful life Finite-Lived Intangible Asset, Useful Life Acquisition accounting inventory fair value step-up adjustments Fair Value Inventory Step Up Adjustment The noncash expense recognized in the current period from the amortization of acquired inventory written up to fair value in purchase accounting. Intangible asset amortization Advertising expenses Advertising Expense Interest rate Debt Instrument, Interest Rate, Stated Percentage Number of shares issuable from exchangeable senior notes Debt Instrument, Convertible, Number of Equity Instruments Debt conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price Payables and Accruals [Abstract] Rebates and other sales deductions Accrued Rebates And Other Sales Deductions Carrying value as of the balance sheet date of obligations incurred through that date and payable for rebates and other sales deductions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Employee compensation and benefits Accrued Employee Benefits, Current Contract claim settlement Contract Claim Settlement Liabilities, Current Amounts payable for contract claim settlements. Sales returns reserve Sales Return Reserve Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales returns reserve. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Royalties Accrued Royalties, Current Accrued interest Accrued Interest Carrying value as of the balance sheet date of obligations incurred through that date and payable for interest. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Professional fees Accrued Professional Fees, Current Accrued construction-in-progress Accrued Construction-In-Progress Carrying value as of the balance sheet date of obligations incurred through that date and payable for construction-in-progress. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Other Other Accrued Liabilities, Current Total accrued liabilities Accrued Liabilities, Current Segment Reporting [Abstract] Concentration Risk [Table] Concentration Risk [Table] Customer Concentration Risk [Member] Customer Concentration Risk [Member] Sales Revenue, Goods, Net [Member] Sales Revenue, Goods, Net [Member] Concentration Risk [Line Items] Concentration Risk [Line Items] Construction-in-progress Computer software Capitalized Computer Software, Gross Leasehold improvements Leasehold Improvements, Gross Computer equipment Computer Equipment, Gross Amount before accumulated depreciation of computer equipment used in the normal conduct of business to produce goods and services and not intended for resale. Machinery and equipment Machinery and Equipment, Gross Furniture and fixtures Furniture and Fixtures, Gross Land and buildings Land and Buildings, Gross Amount of real estate held for productive use and amount before accumulated depreciation of building structures held for productive use. Subtotal Property, Plant and Equipment, Gross Less accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property and equipment, net Property, Plant and Equipment, Net Loss Contingencies [Table] Loss Contingencies [Table] Litigation Status [Axis] Litigation Status [Axis] Litigation Status [Domain] Litigation Status [Domain] Pending Litigation [Member] Pending Litigation [Member] Settled Litigation [Member] Settled Litigation [Member] Litigation Case [Axis] Litigation Case [Axis] Litigation Case [Domain] Litigation Case [Domain] Xyrem ANDA Matters [Member] Xyrem ANDA Matters [Member] Xyrem ANDA Matters [Member] FazaClo, Cutler Matter [Member] FazaClo, Cutler Matter [Member] FazaClo, Cutler Matter [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Number of patents allegedly infringed upon Gain Contingency, Patents Allegedly Infringed upon, Number Term of court ordered stay Loss Contingency, Court Ordered Stay, Term Court ordered stay period for the contingency. Number of claims filed Gain Contingency, New Claims Filed, Number Gain Contingency, New Claims Filed, Number Number of patents named in IPR Petitions Number Of Patents Named In Inter Partes Review (IPR) Petitions Total number of patents named in petitions for inter partes review (IPR). Amount sought in alleged breach of contractual obligation Loss Contingency, Damages Sought, Value Number of radiopharmaceutical products Number Of Radiopharmaceutical Products Number Of Radiopharmaceutical Products Fair Value Measurement Fair Value Disclosures [Text Block] Statement of Cash Flows [Abstract] Operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Net income Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Share-based compensation Share-based Compensation Depreciation Depreciation Loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Excess tax benefit from share-based compensation Excess Tax Benefit from Share-based Compensation, Operating Activities Change in fair value of contingent consideration Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset Deferred income taxes Deferred Income Tax Expense (Benefit) Provision for losses on accounts receivable and inventory Provision For Losses On Accounts Receivable And Inventory Amount of the current period expense charged against operations (1) for the purpose of reducing receivables to an amount that approximates their net realizable value and (2) the charge to cost of goods sold that represents the reduction off the carrying amount of inventory, generally attributable to obsolescence or market conditions. Amortization of debt discount and deferred financing costs Amortization of Financing Costs and Discounts Other non-cash transactions Other Noncash Income (Expense) Changes in assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Inventories Increase (Decrease) in Inventories Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Other long-term assets Increase (Decrease) in Other Noncurrent Assets Accounts payable Increase (Decrease) in Accounts Payable Accrued liabilities Increase (Decrease) in Accrued Liabilities Income taxes payable Increase (Decrease) in Income Taxes Payable Deferred revenue Increase (Decrease) in Deferred Revenue Contingent consideration Increase Decrease in Contingent Consideration Increase Decrease in Contingent Consideration Other non-current liabilities Increase (Decrease) in Other Noncurrent Liabilities Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Acquisition of in-process research and development Payments to Acquire In Process Research and Development Other Than Through Business Combination Payments to Acquire In Process Research and Development Other Than Through Business Combination Purchases of property and equipment Payments to Acquire Productive Assets Net proceeds from sale of business Proceeds from Divestiture of Businesses Acquisition of intangible assets Payments to Acquire Intangible Assets Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Net proceeds from issuance of debt Proceeds from Issuance of Debt Proceeds from employee equity incentive and purchase plans and exercise of warrants Proceeds From Employee Stock Purchases And Exercise Of Stock Options And Warrants The total cash inflow associated with the amount received from holders to acquire the entity's shares under incentive and share awards, including stock option exercises and from holders exercising their stock warrants. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately. Share repurchases Payments for Repurchase of Common Stock Acquisition of noncontrolling interests Payments to Acquire Additional Interest in Subsidiaries Payment of contingent consideration Payments for Previous Acquisition Payment of employee withholding taxes related to share-based awards Payments Related to Tax Withholding for Share-based Compensation Excess tax benefit from share-based compensation Excess Tax Benefit from Share-based Compensation, Financing Activities Repayments of long-term debt Repayments of Secured Debt Repayments under revolving credit facility Repayments of Lines of Credit Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rates on cash and cash equivalents Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations Net increase in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents, at beginning of period Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents, at end of period Supplemental disclosure of cash flow information: Supplemental Cash Flow Information [Abstract] Cash paid for interest Interest Paid, Net Cash paid for income taxes Income Taxes Paid Non-cash investing activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Construction-in-progress related to facility lease obligation Construction in Progress Expenditures Incurred but Not yet Paid Document And Entity Information [Abstract] Document And Entity Information Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Trading Symbol Trading Symbol Entity Filer Category Entity Filer Category Current Fiscal Year End Date Current Fiscal Year End Date Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Voluntary Filers Entity Voluntary Filers Entity Current Reporting Status Entity Current Reporting Status Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Entity Public Float Entity Public Float Statement of Stockholders' Equity [Abstract] Statement [Table] Statement [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Ordinary Shares [Member] Common Stock [Member] Non-voting Euro Deferred [Member] Euro Deferred Shares [Member] Euro Deferred Shares [Member] Capital Redemption Reserve [Member] Capital Redemption Reserve [Member] Capital Redemption Reserve [Member] Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Accumulated Other Comprehensive Income (Loss) [Member] AOCI Attributable to Parent [Member] Retained Earnings (Accumulated Deficit) [Member] Retained Earnings [Member] Total Jazz Pharmaceuticals plc Shareholders' Equity [Member] Parent [Member] Noncontrolling Interest [Member] Noncontrolling Interest [Member] Statement [Line Items] Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Balance, beginning of period Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Balance, shares, beginning of period Shares, Outstanding Noncontrolling interest on Gentium Acquisition Noncontrolling Interest, Increase from Business Combination Acquisition of noncontrolling interest Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests Issuance of exchangeable senior notes Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt Issuance of ordinary shares in conjunction with exercise of share options Stock Issued During Period, Value, Stock Options Exercised Issuance of ordinary shares in conjunction with exercise of share options, shares Stock Issued During Period Shares Stock Options Exercised Net Of Tax Number of net share options exercised during the current period. Issuance of ordinary shares under employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Issuance of ordinary shares under employee stock purchase plan, shares Stock Issued During Period, Shares, Employee Stock Purchase Plans Issuance of ordinary shares in conjunction with vesting of restricted stock units, shares Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Shares withheld for payment of employee's withholding tax liability Adjustments Related to Tax Withholding for Share-based Compensation Issuance of ordinary shares in conjunction with exercise of warrants Stock Issued During Period Value Warrants Exercised Value stock issued during the period as a result of warrants exercised Issuance of ordinary shares in conjunction with exercise of warrants, shares Stock Issued During Period Shares Warrants Exercised Number of shares issued during the period related to warrants exercised Shares issued under directors deferred compensation plan, shares Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Share-based compensation Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Excess tax benefits from employee share options Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net Shares repurchased Stock Repurchased and Retired During Period, Value Stock repurchased, shares Stock Repurchased and Retired During Period, Shares Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax Net income Balance, end of period Balance, shares, end of period Number of operating business segment Number of Operating Segments Statement of Financial Position [Abstract] ASSETS Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Accounts receivable, net of allowances of $3,693 and $3,483 at December 31, 2015 and 2014, respectively Accounts Receivable, Net, Current Inventories Prepaid expenses Prepaid Expense, Current Deferred tax assets, net Deferred Tax Assets, Net, Current Other current assets Other Assets, Current Assets held for sale Disposal Group, Including Discontinued Operation, Assets, Current Total current assets Assets, Current Property and equipment, net Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Goodwill Goodwill Deferred tax assets, net, non-current Deferred Tax Assets, Net of Valuation Allowance, Noncurrent Deferred financing costs Deferred Finance Costs, Current, Net Other non-current assets Other Assets, Noncurrent Total assets Assets LIABILITIES AND SHAREHOLDERS’ EQUITY Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Accounts payable Accounts Payable, Current Accrued liabilities Current portion of long-term debt Long-term Debt, Current Maturities Income taxes payable Taxes Payable, Current Deferred tax liability, net Deferred Tax Liabilities, Net, Current Deferred revenue Deferred Revenue, Current Total current liabilities Liabilities, Current Deferred revenue, non-current Deferred Revenue, Noncurrent Long-term debt, less current portion Long-term Debt, Excluding Current Maturities Deferred tax liability, net, non-current Deferred Tax Liabilities, Net, Noncurrent Other non-current liabilities Other Liabilities, Noncurrent Commitments and contingencies (Note 11) Commitments and Contingencies Shareholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Ordinary shares, nominal value $0.0001 per share; 300,000 shares authorized; 61,305 and 60,643 shares issued and outstanding at December 31, 2015 and 2014, respectively Common Stock, Value, Issued Non-voting euro deferred shares, €0.01 par value per share; 4,000 shares authorized, issued and outstanding at both December 31, 2015 and 2014 Nonvoting Euro Deferred Shares Shares issued to satisfy statutory minimum of Euro-denominated share capital required for a public limited company incorporated in Ireland. Capital redemption reserve Capital Redemption Reserve Capital redemption reserve created under Irish company law to preserve permanent capital in the company. Additional paid-in capital Additional Paid in Capital, Common Stock Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Retained earnings Retained Earnings (Accumulated Deficit) Total Jazz Pharmaceuticals plc shareholders’ equity Stockholders' Equity Attributable to Parent Noncontrolling interests Stockholders' Equity Attributable to Noncontrolling Interest Total shareholders’ equity Total liabilities and shareholders’ equity Liabilities and Equity Deferred Revenue Other Liabilities Disclosure [Text Block] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Ireland [Member] IRELAND United States [Member] UNITED STATES Other [Member] Other Countries [Member] Other Countries [Member] Revenues from External Customers and Long-Lived Assets [Line Items] Revenues from External Customers and Long-Lived Assets [Line Items] Long-lived assets Equity [Abstract] Comprehensive Loss Comprehensive Income (Loss) Note [Text Block] Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Balance at the beginning of the year Unrecognized Tax Benefits Increases related to current year tax positions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Increases related to prior year tax positions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Decreases related to prior year tax positions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Lapse of the applicable statute of limitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Balance at the end of the year Discontinued Operations and Disposal Groups [Abstract] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Selling, General and Administrative [Member] Selling, General and Administrative Expenses [Member] Disposal Group Name [Axis] Disposal Group Name [Axis] Disposal Groups, Including Discontinued Operations, Name [Domain] Disposal Group Name [Domain] Certain EUSA Products [Member] Portion Of EUSA [Member] Portion Of EUSA [Member] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Consideration Disposal Group, Including Discontinued Operation, Consideration Loss on disposal Gain (Loss) on Disposition of Business Disposition Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Components of Inventories Schedule of Inventory, Current [Table Text Block] Effective Income Tax Rate Reconciliation [Abstract] Effective Income Tax Rate Reconciliation, Percent [Abstract] Foreign income tax rate differential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Change in tax rate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Research and other tax credits Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Change in unrecognized tax benefits Effective Income Tax Rate Reconciliation, Tax Contingency, Percent Deduction on subsidiary equity Effective Income Tax Rate Reconciliation, Deduction On Subsidiary Equity, Percent Effective Income Tax Rate Reconciliation, Deduction On Subsidiary Equity, Percent Change in estimates Effective Income Tax Rate Reconciliation, Change In Estimate, Percent Effective Income Tax Rate Reconciliation, Change In Estimate, Percent Non-deductible compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Compensation Cost, Percent Change in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Financing costs Effective Income Tax Rate Reconciliation, Nondeductible Expense, Financing Costs, Percent Effective Income Tax Rate Reconciliation, Nondeductible Expense, Financing Costs, Percent Acquisition-related costs Effective Income Tax Rate Reconciliation, Nondeductible Expense, Acquisition Related Costs, Percent Effective Income Tax Rate Reconciliation, Nondeductible Expense, Acquisition Related Costs, Percent Other Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Effective income tax rate Stockholders' Equity Note [Table] Stockholders Equity Note [Table] Stockholders Equity Note [Table] Award Type [Axis] Award Type [Axis] Award Type [Domain] Equity Award [Domain] Ordinary Shares [Member] Ordinary Shares [Member] Ordinary Shares [Member] Share Repurchase Program [Axis] Share Repurchase Program [Axis] Share Repurchase Program [Domain] Share Repurchase Program [Domain] May 2013 Share Repurchase Program [Member] May 2013 Share Repurchase Program [Member] May 2013 Share Repurchase Program [Member] November 2015 Share Repurchase Program [Member] November 2015 Share Repurchase Program [Member] November 2015 Share Repurchase Program [Member] Stockholders' Equity Note [Line Items] Stockholders Equity Note [Line Items] Stockholders Equity Note [Line Items] Total amount authorized for repurchase of shares under share repurchase program Stock Repurchase Program, Authorized Amount Share repurchases Stock Repurchased During Period, Value Stock repurchased, shares Stock Repurchased During Period, Shares Treasury stock acquired, average cost per share (in dollars per share) Treasury Stock Acquired, Average Cost Per Share Remaining amount authorized for repurchase of shares Stock Repurchase Program, Remaining Authorized Repurchase Amount Schedule of Finite-Lived Intangible Assets by Major Class [Table] Schedule of Finite-Lived Intangible Assets [Table] Manufacturing Contracts [Member] Manufacturing Contracts [Member] Manufacturing Contracts [Member] Trademarks [Member] Trademarks [Member] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] In Process Research and Development [Member] In Process Research and Development [Member] Finite-Lived and Indefinite Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Remaining Weighted- Average Useful Life (In years) Gross Carrying Amount Finite-Lived Intangible Assets, Gross Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Total Finite-Lived Intangible Assets, Net Acquired IPR&D assets Indefinite-lived Intangible Assets Acquired Intangible assets, gross Intangible Assets, Gross (Excluding Goodwill) Intangible assets, net Impairment charge Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Components of Income from Continuing Operations before Income Tax Provision (Benefit) Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Details of Income Tax Provision (Benefit) Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Reconciliation of Income Taxes at the Statutory Income Tax Rate to Effective Income Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of Net Deferred Tax Assets/(Liabilities) Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Reconciliation of Unrecognized Tax Benefits Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share Options [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Grant date fair value (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected term (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Range of risk-free rates, minimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Range of risk-free rates, maximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Expected dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Debt Debt Disclosure [Text Block] Statement of Comprehensive Income [Abstract] Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Total comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Comprehensive loss attributable to noncontrolling interests, net of tax Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive income (loss) attributable to Jazz Pharmaceuticals plc Comprehensive Income (Loss), Net of Tax, Attributable to Parent Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization and Description of Business Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Components of Net Deferred Tax Assets/(Liabilities) Components of Deferred Tax Assets and Liabilities [Abstract] Deferred tax assets: Deferred Tax Assets, Gross [Abstract] Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Tax credit carryforwards Deferred Tax Assets, Tax Credit Carryforwards Intangible assets Deferred Tax Assets, Goodwill and Intangible Assets Share-based compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Accruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals Other Deferred Tax Assets, Other Total deferred tax assets Deferred Tax Assets, Gross Valuation allowance Net deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Deferred tax liabilities: Deferred Tax Liabilities, Gross [Abstract] Acquired intangible assets Deferred Tax Liabilities, Intangible Assets Other Deferred Tax Liabilities, Other Total deferred tax liabilities Deferred Tax Liabilities, Gross Net deferred tax liabilities Deferred Tax Liabilities, Net Compensation and Retirement Disclosure [Abstract] Defined Contribution Plan [Table] Defined Contribution Plan [Table] France [Member] Defined Contribution Plan Disclosure [Line Items] Defined Contribution Plan Disclosure [Line Items] Expenses related to defined contribution plans Defined Contribution Plan, Cost Recognized Defined contribution plans, employer matching percentage of employee's eligible contributions Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Accrued retirement liability Accrued Retirement Liability The accrued retirement liability balance as of the period date for defined contribution plans. Segment and Other Information Segment Reporting Disclosure [Text Block] Fair Value, Option, Qualitative Disclosures Related to Election [Table] Fair Value, Option, Qualitative Disclosures Related to Election [Table] Measurement Frequency [Axis] Measurement Frequency [Axis] Fair Value, Measurement Frequency [Domain] Fair Value, Measurement Frequency [Domain] Fair Value, Measurements, Recurring [Member] Fair Value, Measurements, Recurring [Member] Eligible Item or Group for Fair Value Option [Axis] Eligible Item or Group for Fair Value Option [Axis] Fair Value, Option, Eligible Item or Group [Domain] Fair Value, Option, Eligible Item or Group [Domain] Time Deposits [Member] Bank Time Deposits [Member] Measurement Basis [Axis] Measurement Basis [Axis] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Portion at Fair Value Measurement [Member] Portion at Fair Value Measurement [Member] Estimate of Fair Value, Fair Value Disclosure [Member] Estimate of Fair Value Measurement [Member] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Available-for-sale securities Available-for-sale Securities Numerator: Numerator [Abstract] Numerator [Abstract] Net income attributable to Jazz Pharmaceuticals plc Denominator: Denominator [Abstract] Denominator [Abstract] Weighted-average ordinary shares used in calculating net income per ordinary share attributable to Jazz Pharmaceuticals plc - basic (in shares) Dilutive effect of employee equity incentive and purchase plans (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Dilutive effect of warrants (in shares) Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants Weighted-average ordinary shares used in calculating net income per ordinary share attributable to Jazz Pharmaceuticals plc - diluted (in shares) Net income attributable to Jazz Pharmaceuticals plc per ordinary share : Earnings Per Share [Abstract] Accrued Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Income Tax Benefit Income Tax Expense (Benefit), Continuing Operations [Abstract] Current Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Ireland Current Federal Tax Expense (Benefit) United States Current Foreign Tax Expense (Benefit) Other Other Tax Expense (Benefit) Total current income tax Current Income Tax Expense (Benefit) Deferred Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Ireland Deferred Federal Income Tax Expense (Benefit) United States Deferred Foreign Income Tax Expense (Benefit) Other Deferred Other Tax Expense (Benefit) Total deferred, exclusive of other components Deferred Income Tax Expense (Benefit), Before Effect Of Change In Tax Rates Deferred Income Tax Expense (Benefit), Before Effect Of Change In Tax Rates Deferred, change in tax rates Deferred Income Tax Expense (Benefit), Change In Tax Rate [Abstract] Deferred Income Tax Expense (Benefit), Change In Tax Rate [Abstract] United States Deferred Foreign Income Tax Expense (Benefit), Increase (Decrease) In Tax Rate Deferred Foreign Income Tax Expense (Benefit), Increase (Decrease) In Tax Rate Other Deferred Other Income Tax Expense (Benefit), Increase (Decrease) In Tax Rate Deferred Other Income Tax Expense (Benefit), Increase (Decrease) In Tax Rate Total deferred, change in tax rates Deferred Income Tax Expense (Benefit), Increase (Decrease) In Tax Rate Deferred Income Tax Expense (Benefit), Increase (Decrease) In Tax Rate Total deferred income tax benefit Total income tax provision Restricted Stock Units (RSUs) [Member] Restricted Stock Units (RSUs) [Member] Number of RSUs [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Number of RSUs, outstanding, beginning balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Number of RSUs granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Number of RSUs released (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Number of RSUs forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Number of RSUs expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expired in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expired in Period Number of RSUs, outstanding, ending balance (in shares) Weighted-Average Grant-Date Fair Value [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Weighted-average grant-date fair value, outstanding, beginning balance (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted-average grant-date fair value, RSUs granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted-average grant-date fair value, RSUs released (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Weighted-average grant-date fair value, RSUs forfeited (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Weighted-average grant-date fair value, RSUs expired (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expirations, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expirations, Weighted Average Grant Date Fair Value Weighted-average grant-date fair value, outstanding, ending balance (in dollars per share) Weighted-average remaining contractual term, outstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms Aggregate intrinsic value, outstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Defitelio/defibrotide [Member] Defitelio [Member] Defitelio [Member] Prialt® (ziconotide) intrathecal infusion [Member] Prialt [Member] Prialt [Member] Psychiatry [Member] Psychiatry [Member] Psychiatry [Member] Other [Member] Other Segments [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Ordinary Shares and RSUs [Member] Stock Compensation Plan [Member] Convertible Debt Securities [Member] Convertible Debt Securities [Member] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Anti-dilutive securities (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Schedule Of Interim Financial Information Of Results Of Operations On Quarterly Basis Schedule of Quarterly Financial Information [Table Text Block] Components of Accumulated Other Comprehensive Income/(Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] 2016 Operating Leases, Future Minimum Payments Due, Next Twelve Months 2017 Operating Leases, Future Minimum Payments, Due in Two Years 2018 Operating Leases, Future Minimum Payments, Due in Three Years 2019 Operating Leases, Future Minimum Payments, Due in Four Years 2020 Operating Leases, Future Minimum Payments, Due in Five Years Thereafter Operating Leases, Future Minimum Payments, Due Thereafter Total Property and Equipment Property, Plant and Equipment Disclosure [Text Block] Components of Income from Continuing Operations before Income Tax Provision (Benefit) Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest [Abstract] Ireland Income (Loss) from Continuing Operations before Income Taxes, Domestic United States Income (Loss) from Continuing Operations before Income Taxes, Foreign Other Income (Loss) From Continuing Operations, Before Income Taxes, Other Income (Loss) From Continuing Operations, Before Income Taxes, Other Total Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Employee Benefit Plans Pension and Other Postretirement Benefits Disclosure [Text Block] 2016 Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months 2017 Finite-Lived Intangible Assets, Amortization Expense, Year Two 2018 Finite-Lived Intangible Assets, Amortization Expense, Year Three 2019 Finite-Lived Intangible Assets, Amortization Expense, Year Four 2020 Finite-Lived Intangible Assets, Amortization Expense, Year Five Thereafter Finite-Lived Intangible Assets, Amortization Expense, after Year Five Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Carrying amount of long-term debt Long-term Debt Convertible debt fair value Convertible Debt, Fair Value Disclosures Schedule of Authorized But Unissued Ordinary Shares Schedule of Stock by Class [Table Text Block] Line of Credit Facility [Table] Line of Credit Facility [Table] Term Loan [Member] Term Loan [Member] Term Loan [Member] Revolving Credit Facility [Member] Revolving Credit Facility [Member] Prime Rate [Member] Prime Rate [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Credit Agreement June 2015 [Member] Credit Agreement June 2015 [Member] Credit Agreement June 2015 [Member] Credit Agreement 2012 [Member] Credit Agreement 2012 [Member] Credit Agreement 2012 [Member] Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] London Interbank Offered Rate (LIBOR) [Member] London Interbank Offered Rate (LIBOR) [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Principle amount of long term debt Debt Instrument, Face Amount Maximum amount available under revolving credit facility Line of Credit Facility, Maximum Borrowing Capacity Amount outstanding under revolving credit facility Long-term Line of Credit Extinguishment of debt Extinguishment of Debt, Amount Maturity date Debt Instrument, Maturity Date Debt instrument, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Commitment fee percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Interest rate during the period Debt Instrument, Interest Rate During Period Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Outstanding letters of credit Letters of Credit Outstanding, Amount Principal repayment in year one and two (percent) Debt Instrument, Principal Repayment In Year One And Two, Percent Debt Instrument, Principal Repayment In Year One And Two, Percent Principal repayment in year three (percent) Debt Instrument, Principal Repayment In Year Three, Percent Debt Instrument, Principal Repayment In Year Three, Percent Principal repayment in year four (percent) Debt Instrument, Principal Repayment In Year Four, Percent Debt Instrument, Principal Repayment In Year Four, Percent Principal repayment in year five (percent) Debt Instrument, Principal Repayment In Year Five, Percent Debt Instrument, Principal Repayment In Year Five, Percent Unamortized deferred financing costs and unamortized discount Write Off Of Unamortized Deferred Financing Costs And Unamortized Discount Write-off of amounts previously capitalized as original issue discount and deferred financing costs in an extinguishment of debt. Debt issuance cost Debt Issuance Cost Frequency of periodic payment Debt Instrument, Frequency of Periodic Payment Percentage of conversion price Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger Number of trading days Debt Instrument, Convertible, Threshold Trading Days Number of consecutive days in trading period Debt Instrument, Convertible, Threshold Consecutive Trading Days Conversion rate of shares Debt Instrument, Convertible, Conversion Ratio Conversion denominator Debt Instrument, Convertible, Conversion Denominator Debt Instrument, Convertible, Conversion Denominator Debt term Debt Instrument, Term Carrying value of the equity component Debt Instrument, Convertible, Carrying Amount of Equity Component Cash [Member] Cash [Member] Schedule of Available-for-sale Securities [Line Items] Schedule of Available-for-sale Securities [Line Items] Amortized Cost Available-for-sale Securities, Amortized Cost Basis Gross Unrealized Gains Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax Gross Unrealized Losses Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax Estimated Fair Value Cash and Cash Equivalents Schedule Of Lease Expense Under Operating Leases Schedule of Rent Expense [Table Text Block] Schedule Of Future Minimum Lease Payments Under Noncancelable Operating Leases Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Schedule Of Net Income per Ordinary Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule Of Computation Of Diluted Net Income (Loss) Per Share Having Anti-Dilutive Effect Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Goodwill [Roll Forward] Goodwill [Roll Forward] Balance at December 31, 2014 Foreign exchange Goodwill, Translation Adjustments Balance at December 31, 2015 Long-term Debt, Fiscal Year Maturity [Abstract] Long-term Debt, Fiscal Year Maturity [Abstract] 2016 Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months 2017 Long-term Debt, Maturities, Repayments of Principal in Year Two 2018 Long-term Debt, Maturities, Repayments of Principal in Year Three 2019 Long-term Debt, Maturities, Repayments of Principal in Year Four 2020 Long-term Debt, Maturities, Repayments of Principal in Year Five Thereafter Long-term Debt, Maturities, Repayments of Principal after Year Five Total debt Long-term Debt, Gross Plan Name [Axis] Plan Name [Axis] Plan Name [Domain] Plan Name [Domain] 2011 Equity Incentive Plan [Member] Two Thousand Eleven Equity Incentive Plan [Member] Two Thousand Eleven Equity Incentive Plan [Member] 2011 Equity Incentive Plan, Option One [Member] Two Thousand Eleven Equity Incentive Plan, Option One [Member] Two Thousand Eleven Equity Incentive Plan, Option One [Member] 2011 Equity Incentive Plan, Option Two [Member] Two Thousand Eleven Equity Incentive Plan, Option Two [Member] Two Thousand Eleven Equity Incentive Plan, Option Two [Member] 2007 Equity Incentive Plan [Member] Two Thousand Seven Equity Incentive Plan [Member] Two Thousand Seven Equity Incentive Plan [Member] 2007 Employee Stock Purchase Plan [Member] Two Thousand Seven Employee Stock Purchase Plan [Member] Two Thousand Seven Employee Stock Purchase Plan [Member] 2007 Employee Stock Purchase Plan Option One [Member] Two Thousand Seven Employee Stock Purchase Plan Option One [Member] Two Thousand Seven Employee Stock Purchase Plan Option One [Member] 2007 Employee Stock Purchase Plan Option Two [Member] Two Thousand Seven Employee Stock Purchase Plan Option Two [Member] Two Thousand Seven Employee Stock Purchase Plan Option Two [Member] 2007 Directors Option Plan [Member] Two Thousand Seven Non Employee Directors Stock Option Plan [Member] Two Thousand Seven Non-Employee Directors Stock Option Plan [Member] Directors Deferred Plan [Member] Directors Deferred Compensation Plan [Member] Directors Deferred Compensation Plan [Member] Award Group [Axis] Award Group [Axis] Award Group [Axis] Award Group [Domain] Award Group [Domain] Award Group [Domain] Initial Grant [Member] Initial Grant [Member] Initial Grant [Member] Annual Automatic Grant [Member] Annual Automatic Grant [Member] Annual Automatic Grant [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Event [Member] Requisite service periods (in years) Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period Grants expiration period (in years) Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Shares authorized for issuance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Shares authorized for issuance, annual automatic increase, maximum percentage of outstanding shares Share-based Compensation Arrangement by Share-based Payment Award, Annual Automatic Additional Shares Authorization, Percentage of Outstanding Shares Share-based Compensation Arrangement by Share-based Payment Award, Annual Automatic Additional Shares Authorization, Percentage of Outstanding Shares Increase in shares reserved under plan (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized ESPP discount rate Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date ESPP offering period (in months) Share-based Compensation Arrangement by Share-based Payment Award, Offering Period Fixed offering period (months) with respect to the plan. Number of purchase periods within each ESPP offering period Share-based Compensation Arrangement by Share-based Payment Award, Number of Purchase Periods Within Each Offering Period Number of purchase periods within a fixed offering period with respect to the plan. Number of shares available for issuance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Vesting period (in years) Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Shares authorized for issuance under deferred compensation plan (in shares) Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance Recorded expense related to retainer fees earned and deferred Deferred Compensation Arrangement with Individual, Compensation Expense Deferred Compensation Arrangement With Individual Shares Unissued Deferred Compensation Arrangement With Individual Shares Unissued Ordinary shares unissued under Deferred Compensation Plan Recognized tax benefits related to share options exercised Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options Aggregate intrinsic value of share options exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Unrecognized compensation cost related to unvested share options and RSUs Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Unrecognized compensation cost, weighted-average period of recognition (in years) Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition RSUs weighted-average grant date fair value (in dollars per share) Number of RSUs released (in shares) Shares issued (in shares) Shares withheld for tax purposes (in shares) Shares Paid for Tax Withholding for Share Based Compensation Total fair value of shares vested Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value Schedule Of Gross Carrying Amount Of Goodwill Schedule of Goodwill [Table Text Block] Schedule Of Gross Carrying Amounts And Net Book Values Of Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Schedule Of Estimated Future Amortization Costs Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Basis Of Presentation Consolidation, Policy [Policy Text Block] Significant Risks And Uncertainties Significant Risks And Uncertainties [Policy Text Block] Describes risks and uncertainties related to the pharmaceutical industry. Business Acquisitions Business Combinations Policy [Policy Text Block] Concentrations Of Risk Concentrations Of Risk [Policy Text Block] Concentrations Of Risk [Policy Text Block] Cash Equivalents And Marketable Securities Cash Equivalents And Marketable Securities [Policy Text Block] Cash Equivalents And Marketable Securities [Policy Text Block] Inventories Inventory, Policy [Policy Text Block] Property And Equipment Property, Plant and Equipment, Policy [Policy Text Block] Goodwill, Acquired In-Process Research and Development, And Intangible Assets Goodwill and Intangible Assets, Policy [Policy Text Block] Revenue Recognition Revenue Recognition, Policy [Policy Text Block] Cost Of Product Sales Cost of Sales, Policy [Policy Text Block] Research And Development Research and Development Expense, Policy [Policy Text Block] Advertising Expenses Advertising Costs, Policy [Policy Text Block] Income Taxes Income Tax, Policy [Policy Text Block] Foreign Currency Foreign Currency Transactions and Translations Policy [Policy Text Block] Financing Costs Financing Costs [Policy Text Block] Financing Costs [Policy Text Block] Contingencies Commitments and Contingencies, Policy [Policy Text Block] Use Of Estimates Use of Estimates, Policy [Policy Text Block] Net Income per Ordinary Share Earnings Per Share, Policy [Policy Text Block] Share-Based Compensation Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Accumulated Other Comprehensive Income Loss [Table] Accumulated Other Comprehensive Income (Loss) [Table] Foreign Currency Translation Adjustments [Member] Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Parent [Member] Accumulated Other Comprehensive Income Loss [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Increase (Decrease) in Accumulated Other Comprehensive Income (Loss) [Roll Forward] Increase (Decrease) in Accumulated Other Comprehensive Income (Loss) [Roll Forward] Increase (Decrease) in Accumulated Other Comprehensive Income (Loss) [Roll Forward] Balance at December 31, 2014 Other comprehensive loss Balance at December 31, 2015 Restructuring and Related Activities [Abstract] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Restructuring Type [Axis] Restructuring Type [Axis] Type of Restructuring [Domain] Type of Restructuring [Domain] One-time Termination Benefits One-time Termination Benefits [Member] Facility Closing [Member] Facility Closing [Member] Cost of Product Sales [Member] Cost of Sales [Member] Accrued Liabilities [Member] Accrued Liabilities [Member] Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Scenario, Forecast [Member] Scenario, Forecast [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Restructuring Reserve, Beginning Balance Restructuring Reserve Expense Restructuring Charges Payments Payments for Restructuring Restructuring Reserve, Ending Balance Current and Non-current Deferred Tax Assets (Liabilities) [Abstract] Current and Non-current Deferred Tax Assets (Liabilities) [Abstract] Current and Non-current Deferred Tax Assets (Liabilities) [Abstract] Current deferred tax assets Deferred Tax Assets, Net of Valuation Allowance, Current Current deferred tax liabilities Non-current deferred tax assets Non-current deferred tax liabilities Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Convertible Debt 2021 Notes [Member] Other borrowings [Member] Other Borrowing [Member] Other Borrowing [Member] Principal amount Unamortized discount Debt Instrument, Unamortized Discount Total debt Less current portion Total long-term debt Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Research and Development [Member] Research and Development Expense [Member] Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Total share-based compensation expense, pre-tax Allocated Share-based Compensation Expense Tax benefit from share-based compensation expense Employee Service Share-based Compensation, Tax Benefit from Compensation Expense Total share-based compensation expense, net of tax Allocated Share-based Compensation Expense, Net of Tax Inventories Inventory Disclosure [Text Block] Accounts receivable, allowances Allowance for Doubtful Accounts Receivable, Current Ordinary shares, nominal value (in dollars per share) Common Stock, Par or Stated Value Per Share Ordinary shares, number of shares authorized Common Stock, Shares Authorized Ordinary shares, number of shares issued Common Stock, Shares, Issued Ordinary shares, number of shares outstanding Common Stock, Shares, Outstanding Nonvoting Euro Deferred shares, par value (in euros per share) Nonvoting Euro Deferred Shares, Par or Stated Value Per Share Nonvoting Euro Deferred Shares, Par or Stated Value Per Share Nonvoting Euro Deferred shares, number of shares authorized Nonvoting Euro Preferred Shares, Shares Authorized Nonvoting Euro Preferred Shares, Shares Authorized Nonvoting Euro Deferred shares, number of shares issued Nonvoting Euro Deferred Shares, Shares Issued Nonvoting Euro Deferred Shares, Shares Issued Nonvoting Euro Deferred shares, number of shares outstanding Nonvoting Euro Deferred Shares, Shares Outstanding Nonvoting Euro Deferred Shares, Shares Outstanding Shares Subject to Outstanding Options [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Outstanding, beginning balance Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Options granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Options exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Options forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Options expired Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Outstanding, ending balance Vested and expected to vest Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Exercisable, balance Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Weighted Average Exercise Price (in dollars per share) [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Outstanding, beginning balance (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Options granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Options exercised (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Options forfeited (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Options expired (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Outstanding, ending balance (in dollars per share) Vested and expected to vest (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Exercisable (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted Average Remaining Contractual Term and Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Weighted-average remaining contractual term, outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted-average remaining contractual term, vested and expected to vest, exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Weighted-average remaining contractual term, exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Aggregate intrinsic value, outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Aggregate intrinsic value, vested and expected to vest Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Aggregate intrinsic value, exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Share-Based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Schedule of restructuring amounts Restructuring and Related Costs [Table Text Block] Restructuring Restructuring and Related Activities Disclosure [Text Block] Europe [Member] Europe [Member] All other [Member] Total revenues Shareholders' Equity Stockholders' Equity Note Disclosure [Text Block] Schedule of Weighted-Average Assumptions Used in Black-Scholes Option Pricing Model and Resulting Weighted-Average Grant Date Fair Value of Share Options Granted Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of Share-Based Compensation Expense Related to Share Options, RSUs, and Grants under ESPP Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Schedule of Information and Activity Related to Share Option Plans Activity Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of Information and Activity Related to RSUs Activity Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Amended and Restated 2007 Non-Employee Directors Stock Option Plan [Member] Amended and Restated Directors Deferred Compensation Plan [Member] Class of Stock [Line Items] Class of Stock [Line Items] Authorized but unissued ordinary shares reserved (in shares) Common Stock, Capital Shares Reserved for Future Issuance Summary Of Total Revenues Revenue from External Customers by Products and Services [Table Text Block] Summary Of Total Revenues Attributed To Geographic Sources Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block] Summary Of Revenues From Customers Representing More Then 10% Of Total Revenues Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block] Total Long-Lived Assets by Location Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]